Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04JTX
|
|||
| Former ID |
DNCL002979
|
|||
| Drug Name |
BI-224436
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1 | [1] | |
| Company |
Gilead Sciences
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H26N2O4
|
|||
| Canonical SMILES |
CC1=NC2=CC=CC=C2C(=C1C(C(=O)O)OC(C)(C)C)C3=C4C5=C(C=C3)OCCC5=CC=N4
|
|||
| InChI |
1S/C27H26N2O4/c1-15-21(25(26(30)31)33-27(2,3)4)23(17-7-5-6-8-19(17)29-15)18-9-10-20-22-16(12-14-32-20)11-13-28-24(18)22/h5-11,13,25H,12,14H2,1-4H3,(H,30,31)/t25-/m0/s1
|
|||
| InChIKey |
MIXIIJCBELCMCZ-VWLOTQADSA-N
|
|||
| CAS Number |
CAS 1155419-89-8
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor. Antimicrob Agents Chemother. 2014 Jun;58(6):3233-44. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.